Archive for the ‘Cancer / Oncology’ Category
Friday, May 16th, 2008
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced that the Company will present data from three clinical trials of picoplatin, in various tumor types and combinations, at poster sessions during the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) at McCormick ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
Cytopia Limited (ASX: CYT) announced that the abstract for its upcoming oral presentation on CYT997 at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) will be accessible to the public via ASCO's website (http://www.asco.org) from 9pm on Thursday 15 May (US EDT). ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
In the May 15th issue of G&D, Dr. Guillermina Lozano (MD Anderson Cancer Center) and colleagues reveal how the stabilization of a mutated form of p53 affects oncogenesis, and lends startling new insight into the potential pitfalls of using Mdm2 inhibitors for cancer therapy."Our data are both exciting and sobering: ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
Zevalin ([90Y]-ibritumomab tiuxetan) can now be used as first-line consolidation therapy after remission induction in previously untreated patients with follicular lymphoma (FL).1The European Commission (EC) decision is based on data from the First-line Indolent Trial (FIT) study which showed almost a 2 year improvement in progression free survival (PFS) in ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
UnitedHealthcare Specialty Benefits now provides coverage under all of its insured dental plans for a new oral cancer screening test for potential abnormalities inside the mouth, including premalignant lesions and oral cancer. The test, which uses light-contrast technology, can improve a dentist's ability to identify, evaluate and monitor lesions that ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase II clinical trial of IMC-A12, ImClone's fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in patients with advanced hepatocellular cancer (liver cancer) has opened ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
A health committee of the Scottish parliament said the regulations covering sunbeds and tanning machines offered for public use in commercial parlours are "useless" and do not protect the public, after reviewing evidence from the industry, environmental health and medical research. The committee is reviewing the control of tannning ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
New research conducted at Moores Cancer Center at University of California, San Diego shows that the SAVI™ breast brachytherapy applicator, a new approach for delivering accelerated partial breast irradiation (APBI), may provide better protection of healthy tissue than other partial breast irradiation methods. The research team, led by Catheryn Yashar, ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
As unlikely as it sounds, scientists at the Garvan Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture. Analysis of data from Garvan's Dubbo Osteoporosis Epidemiology Study suggests that men with prostate cancer face a 50% higher risk ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
A large genetic study in mice has identified hundreds of genes involved in the development of cancer by examining the DNA of more than 500 lymphomas to find the cancer causing mutations. The study found just over 10,000 mutations in total, which together implicate almost 350 regions in the mouse ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
An anesthetic injection into a collection of nerves in the neck of breast cancer survivors may reduce the severity and frequency of debilitating hot flashes and night awakenings associated with breast cancer treatment, according to a new study published online by The Lancet Oncology and appearing in its June ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
National Breast and Ovarian Cancer Centre has welcomed an additional $31 million funding over five years from the Australian Government to allow all Australian women who have had a mastectomy as a result of breast cancer to access external prostheses. This Federal budget measure will ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
Stem Cells Might Contribute to Vascular Disease - Stem Cells Might Cause More Damage After Vascular SurgeryPhysician-scientists believe that stem cells might play a harmful role in the body's reaction to trauma following common vascular surgery, like angioplasty. A team of scientists - led by Dr. K. Craig Kent, Greenberg-Starr ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
For mesothelioma patients, the addition of chemotherapy to the usualactive symptom control (ASC) does not appear to improve survival orquality of life, according to an article released on May 16, 2008 in TheLancet. Malignant pleural mesothelioma (MPM) is cancer of the mesothelium, theprotective layer that covers the lungs. Generally associated ...
Posted in Cancer / Oncology | No Comments »
Friday, May 16th, 2008
Survivors of childhood cancers treated with the chemotherapy drug cyclophosphamide were five times more likely to develop bladder cancer later in life than the general population. Results of this new research from the United Kingdom were presented during the Annual Scientific Meeting of the American Urological Association (AUA). Survivors originally ...
Posted in Cancer / Oncology | No Comments »